Pathstone Holdings, LLC

Position in ARGX — Argenx SE

CIK 2011612 ENGLEWOOD, NJ

Position in ARGX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,870,519

+$846,266 QoQ

Shares Held

3,094

+11.6% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#176

of 503 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 89% Shared 1% None 11%

Healthcare · as of Jun 30, 2026

Pathstone Holdings, LLC holds $101,065,916 across 56 Biotechnology names. ARGX ranks #8 (2.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,952	$22,825,735
2	REGN	Regeneron Pharmaceuticals, Inc.	13,825	$8,620,440
3	ASND	Ascendis Pharma A/S	20,248	$5,400,545
4	CYTK	Cytokinetics Inc	47,633	$4,057,854
5	JAZZ	Jazz Pharmaceuticals plc	15,152	$3,651,176
6	PTGX	Protagonist Therapeutics, Inc	28,187	$3,455,162
7	RPRX	Royalty Pharma plc	54,725	$3,068,429
8	ARGX	Argenx SE This page	3,094	$2,870,519

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,870,519	3,094	+11.6%	Shares	Defined	2026-08-13
2026-03-31	$2,024,253	2,772	+2.5%	Shares	Defined	2026-05-11
2025-12-31	$2,274,768	2,705	+11.9%	Shares	Other	2026-02-13
2025-09-30	$1,782,681	2,417	+3.4%	Shares	Defined	2025-11-13
2025-06-30	$1,288,199	2,337	+0.6%	Shares	Other	2025-08-12
2025-03-31	$1,375,493	2,324	-3.4%	Shares	Defined	2025-05-15
2024-12-31	$1,479,690	2,406	+3.4%	Shares	Sole	2025-02-14
2024-09-30	$1,260,877	2,326	+29.2%	Shares	Defined	2024-11-07
2024-06-30	$774,501	1,801	+11.6%	Shares	Sole	2024-08-14
2024-03-31	$635,464	1,614	+33.5%	Shares	Sole	2024-05-13
2023-12-31	$459,939	1,209	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.